IRAK3 and metabolic syndrome: Thus, these results indicate that IRAK3 is a potential key inhibitor of chronic inflammation in blood monocytes and adipose tissue macrophages associated with obesity, and related metabolic disorders such as insulin resistance and metabolic syndrome.